Comparative efficacy and safety of adalimumab biosimilars and adalimumab in patients with rheumatoid arthritis presenting an insufficient response to methotrexate: a network meta-analysis.

Lee, Young Ho; Song, Gwan Gyu

Comparative efficacy and safety of adalimumab biosimilars and adalimumab in patients with rheumatoid arthritis presenting an insufficient response to methotrexate: a network meta-analysis.

Lee, Young Ho; Song, Gwan Gyu.

Afiliação

Lee YH; Division of Rheumatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, 73, Goryeodae-ro, Seongbuk-gu, 02841, Seoul, Korea (Republic of). lyhcgh@korea.ac.kr.
Song GG; Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea (Republic of).

Z Rheumatol ; 82(1): 64-70, 2023 Feb.

Article em En | MEDLINE | ID: mdl-33999266

Assuntos

Antirreumáticos; Artrite Reumatoide; Medicamentos Biossimilares; Humanos; Metotrexato/efeitos adversos; Adalimumab/efeitos adversos; Antirreumáticos/efeitos adversos; Medicamentos Biossimilares/efeitos adversos; Metanálise em Rede; Quimioterapia Combinada; Resultado do Tratamento; Teorema de Bayes; Artrite Reumatoide/diagnóstico; Artrite Reumatoide/tratamento farmacológico

Palavras-chave

Adalimumab; Biosimilar; Network meta-analysis; Rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Medicamentos Biossimilares Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google